New injection tested to regrow hair in severe alopecia

NCT ID NCT07311564

Recruiting now Disease control Sponsor: Almirall, S.A. Source: ClinicalTrials.gov ↗

Summary

This study is testing an investigational drug called LAD603 to see if it helps regrow hair in adults with severe to very severe alopecia areata, an autoimmune condition that causes hair loss. About 136 participants will receive either LAD603 or a placebo injection to compare hair regrowth and safety. The main goal is to measure the change in scalp hair loss using a standard scoring tool.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALOPECIA AREATA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Email: •••••@•••••
Contact

Email: •••••@•••••

Locations

Investigator Site 1
RECRUITING

Omaha, Nebraska, 68144, United States

Conditions

Explore the condition pages connected to this study.

ALOPECIA AREATA